Share Information

Other exchanges or trading platforms where Scancell Holdings plc securities are admitted or traded

Scancell Holdings securities are listed on AIM.

The number of securities in issue

The company has an issued share capital of 1,037,781,403 ordinary shares of 0.1p each, all of which are called up and fully paid.

Directors’ Share Options

The Company has granted the following options to current Directors of the Company.

Option holder
Option price per ordinary share
Number of ordinary shares under option
Last day of exercise period
Phil L’Huillier11.7p31,103,44019 February 2035
Lindy Durrant4.5p3,850,00030 July 2026
Lindy Durrant8.15p1,000,00030 April 2030
Lindy Durrant10.5p9,000,00030 January 2028
Lindy Durrant11.7p5,183,90719 February 2035
Lindy Durrant21.25p9,000,0009 September 2031
Sath Nirmalananthan10.1p1,000,00019 May 2034
Sath Nirmalananthan11.7p1,000,00019 February 2035
Jean-Michel Cosséry17.5p3,000,00020 April 2033
Susan Clement Davies17.5p1,000,00020 April 2033

 

At 30 April 2025, there was a total of 100,515,572 outstanding share options granted by the Company, with exercise prices ranging between 4.5p and 21.3p.

Percentage of AIM securities not in public hands

As at 16 September 2025 the percentage of AIM securities not in public hands was: 43.53%

Restrictions on the transfer of securities

There are no restrictions on the transfer of shares.

Identity and percentage holdings of significant shareholders

As at 16 September 2025, the identity and percentage holdings of significant shareholders were:

 
Ordinary shares at 0.1p each
 
Number
Percentage
Redmile Group LLC297,188,36528.64%
Vulpes Life Science Fund and Testudo Fund143,537,03713.83%

 

Director share interests

As at 30 April 2025 shares held by directors of the Company were as follows:

 
Ordinary shares at 0.1p each
 
Number
Percentage
Lindy Durrant2,069,1590.20%
Jean-Michel Cosséry454,5450.04%
Sath Nirmalananthan190,4760.02%